Reata Pharmaceuticals Inc.

Clinical research activity is centered on Friedreich's ataxia, with attention to neurological impairment, progressive motor dysfunction, and measures of functional capacity relevant to daily activity and disease burden.

• Neuromuscular disease
• Movement disorder
• Functional disability

The sponsor’s research interest in this area includes outcomes tied to exercise performance and established clinical rating scales used to track changes in ataxia severity.